In the current study, dynamic enhanced MRI-based radiomics model was applied to predict therapeutic response in hepatocellular carcinoma treated with transcatheter arterial chemoembolization. In order to obtain the optimal radiomics model, we compared the diagnostic performance of the model built by different classifiers.
This abstract and the presentation materials are available to members only; a login is required.